APA (7th ed.) Citation

Ibrahim, S. A., Hassan, H., Vilardo, L., Kumar, S. K., Kumar, A. V., Kelsch, R., . . . Götte, M. (2013). Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling. PLoS ONE, 8(12), 1. https://doi.org/10.1371/journal.pone.0085737

Chicago Style (17th ed.) Citation

Ibrahim, Sherif A., et al. "Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling." PLoS ONE 8, no. 12 (2013): 1. https://doi.org/10.1371/journal.pone.0085737.

MLA (9th ed.) Citation

Ibrahim, Sherif A., et al. "Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling." PLoS ONE, vol. 8, no. 12, 2013, p. 1, https://doi.org/10.1371/journal.pone.0085737.